Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATGross ProfitLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetShares IssuedShares OutstandingShares Outstanding
Ratios

Atara Biotherapeutics (ATRA) Gross Profit (2022 - 2026)

Atara Biotherapeutics filings provide 5 years of Gross Profit readings, the most recent being $392000.0 for Q1 2026.

  • On a quarterly basis, Gross Profit fell 99.5% to $392000.0 in Q1 2026 year-over-year; TTM through Mar 2026 was $22.2 million, a 86.12% decrease, with the full-year FY2025 number at $99.6 million, down 7.76% from a year prior.
  • Gross Profit hit $392000.0 in Q1 2026 for Atara Biotherapeutics, down from $1.5 million in the prior quarter.
  • In the past five years, Gross Profit ranged from a high of $77.7 million in Q1 2025 to a low of -$2.1 million in Q2 2023.
  • Median Gross Profit over the past 5 years was $5.3 million (2022), compared with a mean of $16.7 million.
  • Biggest five-year swings in Gross Profit: plummeted 104.08% in 2023 and later soared 6931.87% in 2024.
  • Atara Biotherapeutics' Gross Profit stood at $221000.0 in 2022, then surged by 676.47% to $1.7 million in 2023, then surged by 1412.7% to $26.0 million in 2024, then plummeted by 94.26% to $1.5 million in 2025, then crashed by 73.71% to $392000.0 in 2026.
  • The last three reported values for Gross Profit were $392000.0 (Q1 2026), $1.5 million (Q4 2025), and $3.3 million (Q3 2025) per Business Quant data.